MELZAP MD 0.25 TABLET contains Clonazepam which belongs to the group of medicines known as Benzodiazepines. It is used to manage seizure disorder (epilepsy) in adults and children and panic disorder with or without fear of open spaces (agoraphobia) in adults.
Epilepsy is a common condition affecting the brain and causes frequent fits or seizures (bursts of electrical activity in the brain). Symptoms include uncontrollable jerking or shaking, loss of consciousness or collapsing. Panic disorder is characterized by sudden occurrence of panic attacks or fear.
During the therapy with MELZAP MD 0.25 TABLET, your doctor may conduct a blood test to determine liver function. Do not consume alcohol while taking MELZAP MD 0.25 TABLET as it may provoke seizures or fits and may worsen side effects which may possibly lead to severe sedation.
MELZAP MD 0.25 TABLET is not recommended for use in patients with myasthenia gravis, acute narrow-angle glaucoma, sleep apnoea, lung diseases and breathing problems, and severe liver diseases. Consult your doctor before taking it.
MELZAP MD 0.25 TABLET should be taken with caution in patients with mild to moderate liver disease, severe kidney disease, low blood pressure, depression, psychosis and schizophrenia. Consult your doctor before taking it.
MELZAP MD 0.25 TABLET is not recommended for use in pregnant women unless considered clearly necessary. Consult your doctor before taking it. MELZAP MD 0.25 TABLET is generally not recommended for use in breastfeeding women unless considered clearly necessary as it may pass through the breast milk. Consult your doctor before taking it.
MELZAP MD 0.25 TABLET should be used with caution in children and elderly patients. Consult your doctor before taking it.
Some specific serious side effects of MELZAP MD 0.25 TABLET include suicidal thoughts or thoughts of self-harming or unusual changes in behaviour or mood. If you have these thoughts, contact your doctor immediately.
The most common side...
No content available
